BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36614323)

  • 1. PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer.
    Liao Y; Badmann S; Kraus F; Topalov NE; Mayr D; Kolben T; Hester A; Beyer S; Mahner S; Jeschke U; Trillsch F; Czogalla B; Burges A
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway.
    Liao Y; Badmann S; Kaltofen T; Mayr D; Schmoeckel E; Deuster E; Mannewitz M; Landgrebe S; Kolben T; Hester A; Beyer S; Burges A; Mahner S; Jeschke U; Trillsch F; Czogalla B
    Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34206491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wild-type BRCA1, but not mutated BRCA1, regulates the expression of the nuclear form of beta-catenin.
    Li H; Sekine M; Tung N; Avraham HK
    Mol Cancer Res; 2010 Mar; 8(3):407-20. PubMed ID: 20215423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway.
    Fang Y; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    Cancer Biomark; 2018; 23(3):405-418. PubMed ID: 30223390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAF-AH Catalytic Subunits Modulate the Wnt Pathway in Developing GABAergic Neurons.
    Livnat I; Finkelshtein D; Ghosh I; Arai H; Reiner O
    Front Cell Neurosci; 2010; 4():. PubMed ID: 20725507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin G-induced malignant progression of MCF-7 cells involves suppression of PAF signaling through induced expression of PAFAH1B2.
    Tanigawa K; Kiriya M; Hayashi Y; Shinden Y; Kijima Y; Natsugoe S; Sumimoto T; Morimoto-Kamata R; Yui S; Hama K; Yokoyama K; Nakamura Y; Suzuki K; Nojiri H; Inoue K; Karasawa K
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Aug; 1867(8):159164. PubMed ID: 35462067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the G994T and R92H genotypes of platelet-activating factor acetylhydrolase with risk of preeclampsia in Chinese women.
    Zhou M; Chen M; Bai H; He GL; Liu QQ; Guan LB; Liu XH; Fan P
    Pregnancy Hypertens; 2020 Apr; 20():19-26. PubMed ID: 32145524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
    Ninio E; Tregouet D; Carrier JL; Stengel D; Bickel C; Perret C; Rupprecht HJ; Cambien F; Blankenberg S; Tiret L
    Hum Mol Genet; 2004 Jul; 13(13):1341-51. PubMed ID: 15115767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced breast cancer cell adherence to the lung endothelium via PAF acetylhydrolase inhibition: a potential mechanism for enhanced metastasis in smokers.
    Kispert SE; Marentette JO; McHowat J
    Am J Physiol Cell Physiol; 2014 Nov; 307(10):C951-6. PubMed ID: 25186013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation.
    Jung HY; Jun S; Lee M; Kim HC; Wang X; Ji H; McCrea PD; Park JI
    Mol Cell; 2013 Oct; 52(2):193-205. PubMed ID: 24055345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sohlh2 inhibits breast cancer cell proliferation by suppressing Wnt/β-catenin signaling pathway.
    Zhang X; Liu R; Zhao N; Ji S; Hao C; Cui W; Zhang R; Hao J
    Mol Carcinog; 2019 Jun; 58(6):1008-1018. PubMed ID: 30720232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of regulatory miRNAs of the Wnt/ β-catenin signaling pathway in tumorigenesis of breast cancer.
    Rahmani F; Tadayyon Tabrizi A; Hashemian P; Alijannejad S; Rahdar HA; Ferns GA; Hassanian SM; Shahidsales S; Avan A
    Gene; 2020 Sep; 754():144892. PubMed ID: 32534060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin α2β1-contacting-mediated activation of Wnt-β-catenin pathway.
    Zuo XX; Yang Y; Zhang Y; Zhang ZG; Wang XF; Shi YG
    Cell Commun Signal; 2019 Nov; 17(1):142. PubMed ID: 31699102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
    Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
    Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF4 participates in Wnt/β-catenin signaling in breast cancer by upregulating β-catenin and mediating its translocation to the nucleus.
    Wang A; Wang J; Ren H; Yang F; Sun L; Diao K; Zhao Z; Song M; Cui Z; Wang E; Wei M; Mi X
    Mol Cell Biochem; 2014 Oct; 395(1-2):211-9. PubMed ID: 24990246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
    Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer.
    Morrow KA; Das S; Meng E; Menezes ME; Bailey SK; Metge BJ; Buchsbaum DJ; Samant RS; Shevde LA
    Oncotarget; 2016 Apr; 7(14):17991-8005. PubMed ID: 26908451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced lncRNA RBM5-AS1 promotes tumorigenesis via activating Wnt/β-catenin signaling in breast cancer.
    Li X; Yang J; Ni R; Chen J; Zhou Y; Song H; Jin L; Pan Y
    Cell Death Dis; 2022 Feb; 13(2):95. PubMed ID: 35110544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.